ST上昇型急性心筋梗塞の診療に関するガイドライン（2013年改訂版）
Guidelines for the management of patients with ST-elevation acute myocardial infarction
（JCS 2013）
文献
501. Hands ME, Rutherford JD, Muller JE, et al. The in-hospital development of cardiogenic shock after myocardial infarction incidence, predictors of
occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989; 14: 40-46; discussion 47-48.
502. Menon V, White H, LeJemtel T, et al. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a
report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000; 36:
1071-1076.
503. Chen EW, Canto JG, Parsons LS, et al. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial
infarction complicated by cardiogenic shock. Circulation 2003; 108: 951-957.
504. Hausmann H, Potapov EV, Koster A, et al. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new
score. Circulation 2002; 106: I203-206.
505. 田中啓治，田中隆，杉本忠彦，他．急性心筋梗塞における大動脈内バルンパンピング（IABP）無効の心原性ショックの病態とこれに対する経皮的心肺補助法
（PCPS）の有用性ならびに問題点．心臓 1995; 27: 793-801.
506. 桃原哲也，住吉徹哉，土師一夫，他．再疎通療法時代における急性心筋梗塞症に合併する心原性ショック例の院内予後─多施設共同研究による．Jpn Circ
J 2000; 64 Suppl. I: 241.
507. Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic
shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38: 152-160.
508. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-
1296.
509. O’Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon
pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012; 126: 1717-1727.
510. Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute
myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141: 933-939.
511. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction.
N Engl J Med 1993; 328: 981-988.
512. Berger PB, Ryan TJ. Inferior myocardial infarction. High-risk subgroups. Circulation 1990; 81: 401-411.
513. 後藤葉一．右室梗塞．冠動脈疾患の集中治療（平盛勝彦，斎藤宗靖，土師一夫，編）．南江堂 1988: 115-122.
514. Robalino BD, Whitlow PL, Underwood DA, et al. Electrocardiographic manifestations of right ventricular infarction. Am Heart J 1989; 118: 138-144.
515. Braat SH, de Zwaan C, Brugada P, et al. Right ventricular involvement with acute inferior wall myocardial infarction identifies high risk of developing
atrioventricular nodal conduction disturbances. Am Heart J 1984; 107: 1183-1187.
516. Bowers TR, O’Neill WW, Grines C, et al. Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998;
338: 933-940.
517. Braat SH, Ramentol M, Halders S, et al. Reperfusion with streptokinase of an occluded right coronary artery: effects on early and late right and left
ventricular ejection fraction. Am Heart J 1987; 113: 257-260.
518a. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force
on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
518b. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of
the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for
the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: E1-E211.
519. Thompson CR, Buller CE, Sleeper LA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a
report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000;
36: 1104-1109.
520. Birnbaum Y, Fishbein MC, Blanche C, et al. Ventricular septal rupture after acute myocardial infarction. N Engl J Med 2002; 347: 1426-1432.
521. Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect
complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators.
Circulation 2000; 101: 27-32.
522. Pretre R, Ye Q, Grunenfelder J, et al. Operative results of“ repair” of ventricular septal rupture after acute myocardial infraction. Am J Cardiol 1999; 84:
785-788.
523. Smyllie JH, Sutherland GR, Geuskens R, et al. Doppler color flow mapping in the diagnosis of ventricular septal rupture and acute mitral regurgitation
after myocardial infarction. J Am Coll Cardiol 1990; 15: 1449-1455.
524. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA
1988; 260: 2088-2093.
525. Nakamura F, Minamino T, Higashino Y, et al. Cardiac free wall rupture in acute myocardial infarction: ameliorative effect of coronary reperfusion. Clin
Cardiol 1992; 15: 244-250.
526. Pollak H, Nobis H, Mlczoch J. Frequency of left ventricular free wall rupture complicating acute myocardial infarction since the advent of thrombolysis.
Am J Cardiol 1994; 74: 184-186.
527. Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll
Cardiol 1996; 27: 1321-1326.
528. Tanaka K, Sato N, Yasutake M, et al. Clinical course, timing of rupture and relationship with coronary recanalization therapy in 77 patients with
ventricular free wall rupture following acute myocardial infarction. J Nippon Med Sch 2002; 69: 481-488.
529. Tanaka K, Sato N, Yasutake M, et al. Clinicopathological characteristics of 10 patients with rupture of both ventricular free wall and septum (double
rupture) after acute myocardial infarction. J Nippon Med Sch 2003; 70: 21-27.
530. Honan MB, Harrell FE, Reimer KA, et al. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990;
16: 359-367.
531. Becker RC, Charlesworth A, Wilcox RG, et al. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late
Assessment of Thrombolytic Efficacy (LATE) study. J Am Coll Cardiol 1995; 25: 1063-1068.
532. Tikiz H, Balbay Y, Atak R, et al. The effect of thrombolytic therapy on left ventricular aneurysm formation in acute myocardial infarction: relationship
to successful reperfusion and vessel patency. Clin Cardiol 2001; 24: 656-662.
533. Fasol R, Lakew F, Wetter S. Mitral repair in patients with a ruptured papillary muscle. Am Heart J 2000; 139: 549-554.
534. Tavakoli R, Weber A, Vogt P, et al. Surgical management of acute mitral valve regurgitation due to post-infarction papillary muscle rupture. J Heart
Valve Dis 2002; 11: 20-25; discussion 26.
535. Muehrcke DD, Daggett WM, Buckley MJ, et al. Postinfarct ventricular septal defect repair: effect of coronary artery bypass grafting. Ann Thorac Surg
1992; 54: 876-882; discussion 882-873.
536. David TE, Armstrong S. Surgical repair of postinfarction ventricular septal defect by infarct exclusion. Semin Thorac Cardiovasc Surg 1998; 10: 105-
110.
537. Menon V, Webb JG, Hillis LD, et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from
the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000; 36: 1110-1116.
538. Maltais S, Ibrahim R, Basmadjian AJ, et al. Postinfarction ventricular septal defects: towards a new treatment algorithm? Ann Thorac Surg 2009; 87:
687-692.
539. Lundblad R, Abdelnoor M, Geiran OR, et al. Surgical repair of postinfarction ventricular septal rupture: risk factors of early and late death. J Thorac
Cardiovasc Surg 2009; 137: 862-868.
540. Fukushima S, Tesar PJ, Jalali H, et al. Determinants of in-hospital and long-term surgical outcomes after repair of postinfarction ventricular septal
rupture. J Thorac Cardiovasc Surg 2010; 140: 59-65.
541. Moreyra AE, Huang MS, Wilson AC, et al. Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction. Am
J Cardiol 2010; 106: 1095-1100.
542. Arnaoutakis GJ, Zhao Y, George TJ, et al. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of
Thoracic Surgeons National Database. Ann Thorac Surg 2012; 94: 436-443; discussion 443-444.
543. Daggett WM, Guyton RA, Mundth ED, et al. Surgery for postmyocardial infarct ventricular septal defect. Ann Surg 1977; 186: 260-271.
544. David TE, Dale L, Sun Z. Postinfarction ventricular septal rupture repair by endocardial patch with infarct exclusion. J Thorac Cardiovasc Surg 1995;
110: 1315-1322.
545. Isoda S, Imoto K, Uchida K, et al. Sandwich technique via right ventricle incision to repair postinfarction ventricular septal defect. J Card Surg 2004; 19:
149-150.
546. Asai T, Hosoba S, Suzuki T, et al. Postinfarction ventricular septal defect: right ventricular approach-the extended“ sandwich” patch. Semin Thorac
Cardiovasc Surg 2012; 24: 59-62.
547. Thiele H, Kaulfersch C, Daehnert I, et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 2009; 30:
81-88.
548. 許俊鋭，野々木宏．急性心筋梗塞後の左室自由壁破裂に対する治療成績の検討：過去5年間の全国アンケート調査．循環器科2001; 50: 517-520.
549. Slater J, Brown RJ, Antonelli TA, et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report
from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36: 1117-
1122.
550. McMullan MH, Maples MD, Kilgore TL, et al. Surgical experience with left ventricular free wall rupture. Ann Thorac Surg 2001; 71: 1894-1898;
discussion 1898-1899.
551. Iemura J, Oku H, Otaki M, et al. Surgical strategy for left ventricular free wall rupture after acute myocardial infarction. Ann Thorac Surg 2001; 71:
201-204.
552. Terashima M, Fujiwara S, Yaginuma GY, et al. Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall
rupture secondary to acute myocardial infarction. Am J Cardiol 2008; 101: 419-421.
553. Canovas SJ, Lim E, Dalmau MJ, et al. Midterm clinical and echocardiographic results with patch glue repair of left ventricular free wall rupture.
Circulation 2003; 108 Suppl 1: II237-240.
554. Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular
dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998; 116: 50-59.
555. Isomura T, Horii T, Suma H, et al. Septal anterior ventricular exclusion operation (Pacopexy) for ischemic dilated cardiomyopathy: treat form not
disease. Eur J Cardiothorac Surg 2006; 29 Suppl 1: S245-250.
556. Frapier JM, Hubaut JJ, Pasquie JL, et al. Large encircling cryoablation without mapping for ventricular tachycardia after anterior myocardial infarction:
long-term outcome. J Thorac Cardiovasc Surg 1998; 116: 578-583.
557. Wellens F, Geelen P, Demirsoy E, et al. Surgical treatment of tachyarrhythmias due to postinfarction left ventricular aneurysm with
endoaneurysmorrhaphy and cryoablation. Eur J Cardiothorac Surg 2002; 22: 771-776.
558. Oliva PB, Hammill SC. The clinical distinction between regional postinfarction pericarditis and other causes of postinfarction chest pain: ancillary
observations regarding the effect of lytic therapy upon the frequency of postinfarction pericarditis, postinfarction angina, and reinfarction. Clin Cardiol
1994; 17: 471-478.
559. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary
Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949-1956.
560. Ohman EM, Califf RM, Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study
Group. Circulation 1990; 82: 781-791.
561. Alter DA, Tu JV, Austin PC, et al. Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and
without on-site revascularization facilities in Canada. J Am Coll Cardiol 2003; 42: 410-419.
562. Wienbergen H, Schiele R, Gitt AK, et al. Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice.
MIR and MITRA Study Groups. Myocardial Infarction Registry. Maximal Individual Therapy in Acute Myocardial Infarction. Am J Cardiol 2001; 87:
782-785, A788.
563. Tofler GH, Muller JE, Stone PH, et al. Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J 1989; 117:
86-92.
564. Wall TC, Califf RM, Harrelson-Woodlief L, et al. Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction
in predicting amount of myocardial damage. The TAMI Study Group. Am J Cardiol 1990; 66: 1418-1421.
565. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of
the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of
Echocardiography). Developed in collaboration with the American Society of Echocardiography. J Am Coll Cardiol 1997; 29: 862-879.
566. Oliva PB, Hammill SC, Talano JV. T wave changes consistent with epicardial involvement in acute myocardial infarction. Observations in patients with
a postinfarction pericardial effusion without clinically recognized postinfarction pericarditis. J Am Coll Cardiol 1994; 24: 1073-1077.
567. Shahar A, Hod H, Barabash GM, et al. Disappearance of a syndrome: Dressler’s syndrome in the era of thrombolysis. Cardiology 1994; 85: 255-258.
568. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001; 345: 1809-1817.
569. Bulkley BH, Roberts WC. Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm. Am J Med 1974;
56: 244-250.
570. Kloner RA, Fishbein MC, Lew H, et al. Mummification of the infarcted myocardium by high dose corticosteroids. Circulation 1978; 57: 56-63.
571. Tanne D, Gottlieb S, Hod H, et al. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and
thrombolytic eras. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups. J Am Coll Cardiol 1997;
30: 1484-1490.
572. Mooe T, Eriksson P, Stegmayr B. Ischemic stroke after acute myocardial infarction. A population-based study. Stroke 1997; 28: 762-767.
573. Mahaffey KW, Granger CB, Sloan MA, et al. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with
thrombolysis: results from GUSTO-I. Circulation 1998; 97: 757-764.
574. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336: 251-257.
575. Bodenheimer MM, Sauer D, Shareef B, et al. Relation between myocardial infarct location and stroke. J Am Coll Cardiol 1994; 24: 61-66.
576. Spirito P, Bellotti P, Chiarella F, et al. Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial
infarction: a two-dimensional echocardiographic study. Circulation 1985; 72: 774-780.
577. Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation 1987; 75: 1004-1011.
578. Nordrehaug JE, Johannessen KA, von der Lippe G. Usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial
infarction. Am J Cardiol 1985; 55: 1491-1493.
579. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North
American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-1425.
580. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study
Group. Lancet 1988; 1: 545-549.
581. Ringleb PA, Bhatt DL, Hirsch AT, et al. Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events Investigators. Benefit of clopidogrel over
aspirin is amplified in patients with a history of ischemic events. Stroke 2004; 35: 528-532.
582. Rothwell PM, Eliasziw M, Gutnikov SA, et al; Carotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised
controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-116.
583. Wholey MH, Wholey M, Mathias K, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 2000; 50: 160-167.
584. Malek AM, Higashida RT, Phatouros CC, et al. Stent angioplasty for cervical carotid artery stenosis in high-risk symptomatic NASCET-ineligible
patients. Stroke 2000; 31: 3029-3033.
585. Yadav JS. Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial. Cleve Clin J Med 2004; 71 Suppl 1: S45-46.
586. 循環器病の診断と治療に関するガイドライン．肺血栓塞栓症および深部静脈血栓症の診断、治療、予防に関するガイドライン（2009年改訂版）．http://www.j-
circ.or.jp/guideline/pdf/JCS2009_andoh_h.pdf（2012年7月閲覧）
587. Dolovich LR, Ginsberg JS, Douketis JD, et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment
of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern
Med 2000; 160: 181-188.
588. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e195S-226S.
589. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-494S.
590. Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;
107: 1692-1711.
591. Engelen DJ, Gorgels AP, Cheriex EC, et al. Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary
artery in acute anterior myocardial infarction. J Am Coll Cardiol 1999; 34: 389-395.
592. Assali AR, Sclarovsky S, Herz I, et al. Comparison of patients with inferior wall acute myocardial infarction with versus without ST-segment elevation
in leads V5 and V6. Am J Cardiol 1998; 81: 81-83.
593. Kosuge M, Ebina T, Hibi K, et al. Implications of ST-segment elevation in leads V5 and V6 in patients with reperfused inferior wall acute myocardial
infarction. Am J Cardiol 2012; 109: 314-319.
594. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 2003; 348: 933-940.
595. Zimetbaum PJ, Krishnan S, Gold A, et al. Usefulness of STsegment elevation in lead III exceeding that of lead II for identifying the location of the totally
occluded coronary artery in inferior wall myocardial infarction. Am J Cardiol 1998; 81: 918-919.
596. Chia BL, Yip JW, Tan HC, et al. Usefulness of ST elevation II/III ratio and ST deviation in lead I for identifying the culprit artery in inferior wall acute
myocardial infarction. Am J Cardiol 2000; 86: 341-343.
597. Kosuge M, Kimura K, Ishikawa T, et al. New electrocardiographic criteria for predicting the site of coronary artery occlusion in inferior wall acute
myocardial infarction. Am J Cardiol 1998; 82: 1318-1322.
598. Zalenski RJ, Rydman RJ, Sloan EP, et al. Value of posterior and right ventricular leads in comparison to the standard 12-lead electrocardiogram in
evaluation of ST-segment elevation in suspected acute myocardial infarction. Am J Cardiol 1997; 79: 1579-1585.
599. Agarwal JB, Khaw K, Aurignac F, et al. Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic, routine
12-lead electrocardiogram. Am J Cardiol 1999; 83: 323-326.
600. Matetzky S, Freimark D, Chouraqui P, et al. Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior
myocardial infarction: application for thrombolytic therapy. J Am Coll Cardiol 1998; 31: 506-511.
occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989; 14: 40-46; discussion 47-48.
502. Menon V, White H, LeJemtel T, et al. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a
report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000; 36:
1071-1076.
503. Chen EW, Canto JG, Parsons LS, et al. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial
infarction complicated by cardiogenic shock. Circulation 2003; 108: 951-957.
504. Hausmann H, Potapov EV, Koster A, et al. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new
score. Circulation 2002; 106: I203-206.
505. 田中啓治，田中隆，杉本忠彦，他．急性心筋梗塞における大動脈内バルンパンピング（IABP）無効の心原性ショックの病態とこれに対する経皮的心肺補助法
（PCPS）の有用性ならびに問題点．心臓 1995; 27: 793-801.
506. 桃原哲也，住吉徹哉，土師一夫，他．再疎通療法時代における急性心筋梗塞症に合併する心原性ショック例の院内予後─多施設共同研究による．Jpn Circ
J 2000; 64 Suppl. I: 241.
507. Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic
shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38: 152-160.
508. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-
1296.
509. O’Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon
pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012; 126: 1717-1727.
510. Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute
myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141: 933-939.
511. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction.
N Engl J Med 1993; 328: 981-988.
512. Berger PB, Ryan TJ. Inferior myocardial infarction. High-risk subgroups. Circulation 1990; 81: 401-411.
513. 後藤葉一．右室梗塞．冠動脈疾患の集中治療（平盛勝彦，斎藤宗靖，土師一夫，編）．南江堂 1988: 115-122.
514. Robalino BD, Whitlow PL, Underwood DA, et al. Electrocardiographic manifestations of right ventricular infarction. Am Heart J 1989; 118: 138-144.
515. Braat SH, de Zwaan C, Brugada P, et al. Right ventricular involvement with acute inferior wall myocardial infarction identifies high risk of developing
atrioventricular nodal conduction disturbances. Am Heart J 1984; 107: 1183-1187.
516. Bowers TR, O’Neill WW, Grines C, et al. Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998;
338: 933-940.
517. Braat SH, Ramentol M, Halders S, et al. Reperfusion with streptokinase of an occluded right coronary artery: effects on early and late right and left
ventricular ejection fraction. Am Heart J 1987; 113: 257-260.
518a. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force
on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
518b. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of
the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for
the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: E1-E211.
519. Thompson CR, Buller CE, Sleeper LA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a
report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000;
36: 1104-1109.
520. Birnbaum Y, Fishbein MC, Blanche C, et al. Ventricular septal rupture after acute myocardial infarction. N Engl J Med 2002; 347: 1426-1432.
521. Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect
complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators.
Circulation 2000; 101: 27-32.
522. Pretre R, Ye Q, Grunenfelder J, et al. Operative results of“ repair” of ventricular septal rupture after acute myocardial infraction. Am J Cardiol 1999; 84:
785-788.
523. Smyllie JH, Sutherland GR, Geuskens R, et al. Doppler color flow mapping in the diagnosis of ventricular septal rupture and acute mitral regurgitation
after myocardial infarction. J Am Coll Cardiol 1990; 15: 1449-1455.
524. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA
1988; 260: 2088-2093.
525. Nakamura F, Minamino T, Higashino Y, et al. Cardiac free wall rupture in acute myocardial infarction: ameliorative effect of coronary reperfusion. Clin
Cardiol 1992; 15: 244-250.
526. Pollak H, Nobis H, Mlczoch J. Frequency of left ventricular free wall rupture complicating acute myocardial infarction since the advent of thrombolysis.
Am J Cardiol 1994; 74: 184-186.
527. Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll
Cardiol 1996; 27: 1321-1326.
528. Tanaka K, Sato N, Yasutake M, et al. Clinical course, timing of rupture and relationship with coronary recanalization therapy in 77 patients with
ventricular free wall rupture following acute myocardial infarction. J Nippon Med Sch 2002; 69: 481-488.
529. Tanaka K, Sato N, Yasutake M, et al. Clinicopathological characteristics of 10 patients with rupture of both ventricular free wall and septum (double
rupture) after acute myocardial infarction. J Nippon Med Sch 2003; 70: 21-27.
530. Honan MB, Harrell FE, Reimer KA, et al. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990;
16: 359-367.
531. Becker RC, Charlesworth A, Wilcox RG, et al. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late
Assessment of Thrombolytic Efficacy (LATE) study. J Am Coll Cardiol 1995; 25: 1063-1068.
532. Tikiz H, Balbay Y, Atak R, et al. The effect of thrombolytic therapy on left ventricular aneurysm formation in acute myocardial infarction: relationship
to successful reperfusion and vessel patency. Clin Cardiol 2001; 24: 656-662.
533. Fasol R, Lakew F, Wetter S. Mitral repair in patients with a ruptured papillary muscle. Am Heart J 2000; 139: 549-554.
534. Tavakoli R, Weber A, Vogt P, et al. Surgical management of acute mitral valve regurgitation due to post-infarction papillary muscle rupture. J Heart
Valve Dis 2002; 11: 20-25; discussion 26.
535. Muehrcke DD, Daggett WM, Buckley MJ, et al. Postinfarct ventricular septal defect repair: effect of coronary artery bypass grafting. Ann Thorac Surg
1992; 54: 876-882; discussion 882-873.
536. David TE, Armstrong S. Surgical repair of postinfarction ventricular septal defect by infarct exclusion. Semin Thorac Cardiovasc Surg 1998; 10: 105-
110.
537. Menon V, Webb JG, Hillis LD, et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from
the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000; 36: 1110-1116.
538. Maltais S, Ibrahim R, Basmadjian AJ, et al. Postinfarction ventricular septal defects: towards a new treatment algorithm? Ann Thorac Surg 2009; 87:
687-692.
539. Lundblad R, Abdelnoor M, Geiran OR, et al. Surgical repair of postinfarction ventricular septal rupture: risk factors of early and late death. J Thorac
Cardiovasc Surg 2009; 137: 862-868.
540. Fukushima S, Tesar PJ, Jalali H, et al. Determinants of in-hospital and long-term surgical outcomes after repair of postinfarction ventricular septal
rupture. J Thorac Cardiovasc Surg 2010; 140: 59-65.
541. Moreyra AE, Huang MS, Wilson AC, et al. Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction. Am
J Cardiol 2010; 106: 1095-1100.
542. Arnaoutakis GJ, Zhao Y, George TJ, et al. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of
Thoracic Surgeons National Database. Ann Thorac Surg 2012; 94: 436-443; discussion 443-444.
543. Daggett WM, Guyton RA, Mundth ED, et al. Surgery for postmyocardial infarct ventricular septal defect. Ann Surg 1977; 186: 260-271.
544. David TE, Dale L, Sun Z. Postinfarction ventricular septal rupture repair by endocardial patch with infarct exclusion. J Thorac Cardiovasc Surg 1995;
110: 1315-1322.
545. Isoda S, Imoto K, Uchida K, et al. Sandwich technique via right ventricle incision to repair postinfarction ventricular septal defect. J Card Surg 2004; 19:
149-150.
546. Asai T, Hosoba S, Suzuki T, et al. Postinfarction ventricular septal defect: right ventricular approach-the extended“ sandwich” patch. Semin Thorac
Cardiovasc Surg 2012; 24: 59-62.
547. Thiele H, Kaulfersch C, Daehnert I, et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 2009; 30:
81-88.
548. 許俊鋭，野々木宏．急性心筋梗塞後の左室自由壁破裂に対する治療成績の検討：過去5年間の全国アンケート調査．循環器科2001; 50: 517-520.
549. Slater J, Brown RJ, Antonelli TA, et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report
from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000; 36: 1117-
1122.
550. McMullan MH, Maples MD, Kilgore TL, et al. Surgical experience with left ventricular free wall rupture. Ann Thorac Surg 2001; 71: 1894-1898;
discussion 1898-1899.
551. Iemura J, Oku H, Otaki M, et al. Surgical strategy for left ventricular free wall rupture after acute myocardial infarction. Ann Thorac Surg 2001; 71:
201-204.
552. Terashima M, Fujiwara S, Yaginuma GY, et al. Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall
rupture secondary to acute myocardial infarction. Am J Cardiol 2008; 101: 419-421.
553. Canovas SJ, Lim E, Dalmau MJ, et al. Midterm clinical and echocardiographic results with patch glue repair of left ventricular free wall rupture.
Circulation 2003; 108 Suppl 1: II237-240.
554. Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular
dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998; 116: 50-59.
555. Isomura T, Horii T, Suma H, et al. Septal anterior ventricular exclusion operation (Pacopexy) for ischemic dilated cardiomyopathy: treat form not
disease. Eur J Cardiothorac Surg 2006; 29 Suppl 1: S245-250.
556. Frapier JM, Hubaut JJ, Pasquie JL, et al. Large encircling cryoablation without mapping for ventricular tachycardia after anterior myocardial infarction:
long-term outcome. J Thorac Cardiovasc Surg 1998; 116: 578-583.
557. Wellens F, Geelen P, Demirsoy E, et al. Surgical treatment of tachyarrhythmias due to postinfarction left ventricular aneurysm with
endoaneurysmorrhaphy and cryoablation. Eur J Cardiothorac Surg 2002; 22: 771-776.
558. Oliva PB, Hammill SC. The clinical distinction between regional postinfarction pericarditis and other causes of postinfarction chest pain: ancillary
observations regarding the effect of lytic therapy upon the frequency of postinfarction pericarditis, postinfarction angina, and reinfarction. Clin Cardiol
1994; 17: 471-478.
559. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary
Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949-1956.
560. Ohman EM, Califf RM, Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study
Group. Circulation 1990; 82: 781-791.
561. Alter DA, Tu JV, Austin PC, et al. Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and
without on-site revascularization facilities in Canada. J Am Coll Cardiol 2003; 42: 410-419.
562. Wienbergen H, Schiele R, Gitt AK, et al. Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice.
MIR and MITRA Study Groups. Myocardial Infarction Registry. Maximal Individual Therapy in Acute Myocardial Infarction. Am J Cardiol 2001; 87:
782-785, A788.
563. Tofler GH, Muller JE, Stone PH, et al. Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J 1989; 117:
86-92.
564. Wall TC, Califf RM, Harrelson-Woodlief L, et al. Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction
in predicting amount of myocardial damage. The TAMI Study Group. Am J Cardiol 1990; 66: 1418-1421.
565. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of
the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Application of
Echocardiography). Developed in collaboration with the American Society of Echocardiography. J Am Coll Cardiol 1997; 29: 862-879.
566. Oliva PB, Hammill SC, Talano JV. T wave changes consistent with epicardial involvement in acute myocardial infarction. Observations in patients with
a postinfarction pericardial effusion without clinically recognized postinfarction pericarditis. J Am Coll Cardiol 1994; 24: 1073-1077.
567. Shahar A, Hod H, Barabash GM, et al. Disappearance of a syndrome: Dressler’s syndrome in the era of thrombolysis. Cardiology 1994; 85: 255-258.
568. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001; 345: 1809-1817.
569. Bulkley BH, Roberts WC. Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm. Am J Med 1974;
56: 244-250.
570. Kloner RA, Fishbein MC, Lew H, et al. Mummification of the infarcted myocardium by high dose corticosteroids. Circulation 1978; 57: 56-63.
571. Tanne D, Gottlieb S, Hod H, et al. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and
thrombolytic eras. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups. J Am Coll Cardiol 1997;
30: 1484-1490.
572. Mooe T, Eriksson P, Stegmayr B. Ischemic stroke after acute myocardial infarction. A population-based study. Stroke 1997; 28: 762-767.
573. Mahaffey KW, Granger CB, Sloan MA, et al. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with
thrombolysis: results from GUSTO-I. Circulation 1998; 97: 757-764.
574. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336: 251-257.
575. Bodenheimer MM, Sauer D, Shareef B, et al. Relation between myocardial infarct location and stroke. J Am Coll Cardiol 1994; 24: 61-66.
576. Spirito P, Bellotti P, Chiarella F, et al. Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial
infarction: a two-dimensional echocardiographic study. Circulation 1985; 72: 774-780.
577. Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation 1987; 75: 1004-1011.
578. Nordrehaug JE, Johannessen KA, von der Lippe G. Usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial
infarction. Am J Cardiol 1985; 55: 1491-1493.
579. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North
American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-1425.
580. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study
Group. Lancet 1988; 1: 545-549.
581. Ringleb PA, Bhatt DL, Hirsch AT, et al. Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events Investigators. Benefit of clopidogrel over
aspirin is amplified in patients with a history of ischemic events. Stroke 2004; 35: 528-532.
582. Rothwell PM, Eliasziw M, Gutnikov SA, et al; Carotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised
controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-116.
583. Wholey MH, Wholey M, Mathias K, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 2000; 50: 160-167.
584. Malek AM, Higashida RT, Phatouros CC, et al. Stent angioplasty for cervical carotid artery stenosis in high-risk symptomatic NASCET-ineligible
patients. Stroke 2000; 31: 3029-3033.
585. Yadav JS. Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial. Cleve Clin J Med 2004; 71 Suppl 1: S45-46.
586. 循環器病の診断と治療に関するガイドライン．肺血栓塞栓症および深部静脈血栓症の診断、治療、予防に関するガイドライン（2009年改訂版）．http://www.j-
circ.or.jp/guideline/pdf/JCS2009_andoh_h.pdf（2012年7月閲覧）
587. Dolovich LR, Ginsberg JS, Douketis JD, et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment
of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern
Med 2000; 160: 181-188.
588. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e195S-226S.
589. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-494S.
590. Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;
107: 1692-1711.
591. Engelen DJ, Gorgels AP, Cheriex EC, et al. Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary
artery in acute anterior myocardial infarction. J Am Coll Cardiol 1999; 34: 389-395.
592. Assali AR, Sclarovsky S, Herz I, et al. Comparison of patients with inferior wall acute myocardial infarction with versus without ST-segment elevation
in leads V5 and V6. Am J Cardiol 1998; 81: 81-83.
593. Kosuge M, Ebina T, Hibi K, et al. Implications of ST-segment elevation in leads V5 and V6 in patients with reperfused inferior wall acute myocardial
infarction. Am J Cardiol 2012; 109: 314-319.
594. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 2003; 348: 933-940.
595. Zimetbaum PJ, Krishnan S, Gold A, et al. Usefulness of STsegment elevation in lead III exceeding that of lead II for identifying the location of the totally
occluded coronary artery in inferior wall myocardial infarction. Am J Cardiol 1998; 81: 918-919.
596. Chia BL, Yip JW, Tan HC, et al. Usefulness of ST elevation II/III ratio and ST deviation in lead I for identifying the culprit artery in inferior wall acute
myocardial infarction. Am J Cardiol 2000; 86: 341-343.
597. Kosuge M, Kimura K, Ishikawa T, et al. New electrocardiographic criteria for predicting the site of coronary artery occlusion in inferior wall acute
myocardial infarction. Am J Cardiol 1998; 82: 1318-1322.
598. Zalenski RJ, Rydman RJ, Sloan EP, et al. Value of posterior and right ventricular leads in comparison to the standard 12-lead electrocardiogram in
evaluation of ST-segment elevation in suspected acute myocardial infarction. Am J Cardiol 1997; 79: 1579-1585.
599. Agarwal JB, Khaw K, Aurignac F, et al. Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic, routine
12-lead electrocardiogram. Am J Cardiol 1999; 83: 323-326.
600. Matetzky S, Freimark D, Chouraqui P, et al. Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior
myocardial infarction: application for thrombolytic therapy. J Am Coll Cardiol 1998; 31: 506-511.